NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
87 hedge funds and large institutions have $82.4M invested in Navidea Biopharmaceuticals Inc. in 2014 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 33 increasing their positions, 18 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
18% less capital invested
Capital invested by funds: $100M → $82.4M (-$18M)
99% less call options, than puts
Call options by funds: $95K | Put options by funds: $9.62M
Holders
87
Holding in Top 10
1
Calls
$95K
Puts
$9.62M
Top Buyers
| 1 | +$1.25M | |
| 2 | +$468K | |
| 3 | +$306K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$209K |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
+$147K |
Top Sellers
| 1 | -$255K | |
| 2 | -$230K | |
| 3 | -$221K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$179K |
| 5 |
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
|
-$173K |